TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia
KOSMIDER, Olivier, GELSI-BOYER, Véronique, STAMATOULAS, Aspasia, DREYFUS, François, IFRAH, Norbert, DE BOTTON, Stéphane, VAINCHENKER, William, BERNARD, Oliver A, BIRNBAUM, Daniel, FONTENAY, Michaëla, SOLARY, Eric, CIUDAD, Marion, RACOEUR, Cindy, JOOSTE, Valérie, VEY, Norbert, QUESNEL, Bruno, FENAUX, Pierre, BASTIE, Jean-Noël, BEYNE-RAUZY, Odile
Published in Haematologica (Roma) (01.12.2009)
Published in Haematologica (Roma) (01.12.2009)
Get full text
Journal Article
Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib
Quek, Lynn, David, Muriel D., Kennedy, Alison, Metzner, Marlen, Amatangelo, Michael, Shih, Alan, Stoilova, Bilyana, Quivoron, Cyril, Heiblig, Maël, Willekens, Christophe, Saada, Véronique, Alsafadi, Samar, Vijayabaskar, M. S., Peniket, Andy, Bernard, Oliver A., Agresta, Sam, Yen, Katharine, MacBeth, Kyle, Stein, Eytan, Vassiliou, George S., Levine, Ross, De Botton, Stephane, Thakurta, Anjan, Penard-Lacronique, Virginie, Vyas, Paresh
Published in Nature medicine (01.08.2018)
Published in Nature medicine (01.08.2018)
Get full text
Journal Article